We are live on ! Find out more
NR

Newfound Research Portfolio holdings

AUM $40.8M
1-Year Est. Return 12.42%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
-12.42%
3 Year Est. Return
+54.59%
5 Year Est. Return
+89.01%
10 Year Est. Return
AUM
$107M
AUM Growth
-$7.36M
Cap. Flow
-$13.8M
Cap. Flow %
-12.91%
Top 10 Hldgs %
43.43%
Holding
240
New
10
Increased
27
Reduced
134
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.92%
2 Financials 0.02%
3 Healthcare 0.01%
4 Technology 0.01%
5 Consumer Staples 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLPS
51
DELISTED
POWERSHARES S&P SMALLCAP CONSUMER STAPLES PORT
XLPS
$7K 0.01%
88
-51
-37% -$4.06K
XLKS
52
DELISTED
POWERSHARES S&P SMALLCAP INFORMATION TECHNOLOGY PORTFOLIO
XLKS
$7K 0.01%
69
-171
-71% -$17.3K
XLIS
53
DELISTED
POWERSHARES S&P SMALLCAP INDUSTRIALS PORTFOLIO
XLIS
$7K 0.01%
92
-126
-58% -$9.59K
XLBS
54
DELISTED
POWERSHARES S&P SMALLCAP MATERIALS PORT
XLBS
$7K 0.01%
147
-24
-14% -$1.14K
XLFS
55
DELISTED
POWERSHARES S&P SMALLCAP FINANCIALS PORTFOLIO
XLFS
$7K 0.01%
122
-264
-68% -$15.1K
USMV icon
56
iShares MSCI USA Min Vol Factor ETF
USMV
$24.5B
$6K 0.01%
88
-30
-25% -$1.93K
NOBL icon
57
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$5K ﹤0.01%
122
-44
-27% -$1.61K
SSO icon
58
ProShares Ultra S&P500
SSO
$8.52B
$5K ﹤0.01%
240
-120
-33% -$2.07K
VGIT icon
59
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.5B
$5K ﹤0.01%
79
+1
+1% +$66
SCIU
60
DELISTED
Global X Scientific Beta US ETF
SCIU
$5K ﹤0.01%
153
XLVS
61
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$5K ﹤0.01%
39
-51
-57% -$6.54K
JPIN icon
62
JPMorgan Diversified Return International Equity ETF
JPIN
$378M
$4K ﹤0.01%
70
MTUM icon
63
iShares MSCI USA Momentum Factor ETF
MTUM
$24.7B
$4K ﹤0.01%
31
-9
-23% -$1.09K
RSP icon
64
Invesco S&P 500 Equal Weight ETF
RSP
$99.8B
$4K ﹤0.01%
34
-12
-26% -$1.33K
TSN icon
65
Tyson Foods
TSN
$19.5B
$4K ﹤0.01%
42
-22
-34% -$1.89K
UST icon
66
ProShares Ultra 7-10 Year Treasury
UST
$14.7M
$4K ﹤0.01%
72
-14
-16% -$893
ALL icon
67
Allstate
ALL
$65.1B
$3K ﹤0.01%
23
-12
-34% -$1.31K
BNDX icon
68
Vanguard Total International Bond ETF
BNDX
$82.7B
$3K ﹤0.01%
47
+1
+2% +$58
ELV icon
69
Elevance Health
ELV
$86.6B
$3K ﹤0.01%
10
-7
-41% -$1.93K
EXC icon
70
Exelon
EXC
$45.3B
$3K ﹤0.01%
97
-45
-32% -$1.46K
MU icon
71
Micron Technology
MU
$1.06T
$3K ﹤0.01%
58
-31
-35% -$1.48K
RPV icon
72
Invesco S&P 500 Pure Value ETF
RPV
$1.73B
$3K ﹤0.01%
49
-16
-25% -$1.07K
VLO icon
73
Valero Energy
VLO
$99.8B
$3K ﹤0.01%
33
-15
-31% -$1.42K
ADM icon
74
Archer Daniels Midland
ADM
$38.1B
$2K ﹤0.01%
42
-27
-39% -$1.15K
AGG icon
75
iShares Core US Aggregate Bond ETF
AGG
$139B
$2K ﹤0.01%
15

Similar funds

Newfound Research's Q4 2019 Portfolio in Review

As of Q4 2019, Newfound Research held 240 positions worth $107M, down 6.5% from $114M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Newfound Research withdrew a net $13.8M in Q4 2019, closing 13 positions and reducing 134 holdings. Its most notable exit was Invesco Senior Loan ETF, an estimated $4.61M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, up from 100% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Newfound Research opened a new position in Paramount Global Class B worth $1K.

  • Newfound Research's largest Q4 2019 buy was Paramount Global Class B: 17 shares worth $1K.
  • Newfound Research added most to iShares Global Energy ETF in Q4 2019, an estimated $1.29M increase.
  • Newfound Research's biggest Q4 2019 reduction was iShares Global Healthcare ETF, cutting an estimated $825K.
  • Newfound Research fully exited Invesco Senior Loan ETF in Q4 2019, selling an estimated $4.61M.
  • Newfound Research's ten largest holdings make up 43% of its $107M portfolio in Q4 2019.
  • Newfound Research opened 10 new positions and closed 13 in Q4 2019.
  • Newfound Research's portfolio value fell 6.5% quarter-over-quarter to $107M.

Based on Newfound Research's 13F filing for Q4 2019, filed 10 Feb 2020.